Loading

International Journal of Plant Biology & Research

Current Status of Genomics Research on Mycotoxigenic Fungi

Mini Review | Open Access

  • 1. USDA-ARS, Beltsville Agricultural Research Center, Food Quality Laboratory, USA
  • 2. Department of Plant Biology and Pathology, Rutgers University, USA
+ Show More - Show Less
Corresponding Authors
Jiujiang Yu, USDA-ARS, Beltsville Agricultural Research Center, Food Quality Laboratory, Beltsville, Maryland, USA, Tel: 301-504-5721; Fax: 301-504- 5107
Abstract

Mold-produced secondary metabolites that are toxic and carcinogenic are termed mycotoxins. They are biosynthesized in a number of fungi, mainly from species in the Aspergillus, Fusarium and Penicillium genera. Mycotoxins contaminate agricultural commodities such as grains, fruits and nuts. Due to their toxic and carcinogenic properties, they pose a serious health hazard to animals and humans and cause staggering economic losses to growers, packers, processors, and consumers annually. Research on major mycotoxins, such as aflatoxins, using molecular biological and genetic tools has uncovered the genes, gene clusters, biosynthetic pathways, and genetic regulatory mechanisms involved in their formation. The field of genomics has empowered scientists with a high throughput tool to study mycotoxin biosynthesis and regulatory networks with a new level of scientific rigor. In this paper, the current status of genomic investigations on mycotoxigenic fungi has been summarized in order to better understand their biosynthesis, genetic regulation, genome structure, and evolutionary aspects. In addition, the advantages, challenges, and future perspectives in studying mycotoxins are discussed. The information and knowledge contained in this chapter may guide possible solutions to abate mycotoxin contamination of agricultural commodities for human consumption and animal feed.

Citation

Yu J, Jurick WM, Bennett JW (2015) Current Status of Genomics Research on Mycotoxigenic Fungi. Int J Plant Biol Res 3(2): 1035.

Keywords

•    Mycotoxins
•    Aflatoxins
•    Patulin
•    Aspergilli
•    Penicillium
•    Fusarium

ABBREVIATIONS

NGS: Next Generation Sequencing; CPA: Cyclopiazonic Acid; DON: Deoxynivalenol; ST: Sterigmatocystin; DHST: Dihydrosterigmatocystin; ORF: Open Reading Frames; FFSC: Fusarium (Gibberella) fujikuroi Species Complex; OTA: Ochratoxin A; SMURF: Secondary Metabolite Unique Region Finder; Antismash: Antibiotics And Secondary Metabolite Analysis Shell; Aspgd: Aspergillus Genome Database.

INTRODUCTION

Mycotoxins and mycotoxigenic fungi

Fungi are diverse and complex life forms. They play an essential role in carbon and nitrogen recycling by breaking down organic matter, especially plant biomass (i.e. leaf litter). The fungal kingdom also includes harmful pathogens that cause diseases of plants, animals, and humans. Some fungi are valued as gourmet foodstuffs that regularly appear on our dining tables (for example, edible basidiomycetes, truffles, and certain mold fermented foods, i.e. camembert cheese) Finally, numerous fungal species are capable of producing a broad array of chemically diverse secondary metabolites (SM) [1]. Some of the SM produced by fungi are beneficial and have useful pharmaceutical properties, such as antibiotics and other compounds used as drugs [2]. For example, Penicillium chrysogenum produces penicillin, a well-known broad spectrum antibiotic drug that has saved thousands of lives since World War II. Aspergillus terreus produces lovastatin, a potent cholesterol-lowering drug. Other Aspergillus species secrete antibiotics (cephalosporin), antifungals (griseofulvin), and anti-tumor drugs (terrequinone A) [1,3] , while a number of SM are toxic and carcinogenic to animals and humans [1,2,4]. Well-studied mycotoxins include aflatoxins, ochratoxins, sterigmatocystins, cyclopiazonic acid (CPA), kojic acid, patulin, citrinin, fumonisins, trichothecenes, deoxynivalenol (DON) toxins, T-2 toxin, and zearalenone toxin [5,6]. These toxins are mostly produced by Aspergillus, Fusarium, and Penicillium spp., although other fungal genera are also implicated.

Food and feed contamination by mycotoxins, especially by aflatoxins, fumonisins, trichothecenes, ochratoxins, and patulin, are a significant food safety issue in developing countries because of the lack of detection, monitoring and regulations to safeguard the food supply. It is estimated that approximately 4.5 billion people living in developing countries are chronically exposed to uncontrolled amounts of aflatoxin that results in negatives changes in immune and nutritional status [7]. Major outbreaks of acute aflatoxicosis from contaminated food in humans have been documented [8]. For example, in western India in 1974, 108 persons among 397 people affected died from aflatoxin poisoning [9]. A more recent incident of aflatoxin poisoning occurred in Kenya in July 2004 leading to the death of 125 people among the 317 reported illnesses due to consumption of aflatoxin contaminated corn [8,9]. Due to their toxic and carcinogenic effects, aflatoxins have received a lot of attention from the research community and the aflatoxin biosynthetic pathway is one of the best studied fungal secondary metabolic pathways [10-12].

The number of uncharacterized secondary compounds produced by fungi via various metabolic pathways is unknown. These include pathway end products and intermediates or shunt metabolites formed along these pathways. These uncharacterized compounds are likely to include many new SM that will have beneficial pharmaceutical properties that can be explored for potential drug discovery, while others may possess toxic or carcinogenic properties. To maximize the likelihood of discovering new drugs and to minimize the harmful effects of mycotoxins for food safety, uncharacterized SM clusters are the subject of investigations by scientists worldwide.

Genomics approaches to study mycotoxins and mycotoxigenic fungi

Technical breakthroughs in DNA sequencing have provided a high throughput tool to study genes and genetics at the genome scale. The availability of Next Generation Sequencing (NGS) technologies allows scientists to sequence a given fungal genome and discover all of the putative functional genes of a genome in a very short time [13-15]. NGS technologies are broadly applied in functional genomics for transcriptome studies. In the post-genomic era, the genomes of numerous biologically and economically important fungi have been sequenced. Comparative genomics analysis of related toxigenic fungal species has revealed a vast array of information concerning mycotoxin biosynthetic pathways, pathway genes, gene clusters, genomic organization, and their evolution. Genome sequencing data enrich our knowledge of the evolutionary status and phylogenetic relationships of related fungal species. It is expected that the genomic data accumulated over the years, and the accompanying knowledge gained through functional genomic studies, can be translated into biotechnological strategies for preventing mycotoxin contamination in food and feed.

DISCUSSION AND CONCLUSION

Aspergillus toxins and genomics

Mycotoxins have very diverse chemical structures, toxic effects, and biological activities [1649]. At sufficient concentrations, some mycotoxins have acute toxic effects leading to death, while long term exposure to lower concentrations results in chronic effects, such as suppressed immune response, malnutrition, or cancer [17,18]. Among the identified mycotoxins, aflatoxins are the most toxic and potent natural carcinogens. These A. flavus toxins were first identified as the cause of a severe animal poisoning incident in England in 1960 called Turkey X disease [19,20]. Most strains of A. flavus produce aflatoxin B1 and B2 whereas the closely related species, A. parasiticus produces aflatoxins B1 , B2 , G1 , and G2 . Further, aflatoxin M1 is a hydroxylated derivative metabolized from aflatoxin B1 by cows and secreted in milk [18]. In addition to aflatoxins, A. flavus also produces many other mycotoxins such as cyclopiazonic acid (CPA), kojic acid, beta-nitropropionic acid, aspertoxin, aflatrem and aspergillic acid [21]. Sterigmatocystin (ST) or dihydrosterigmatocystin (DHST), the penultimate precursors of aflatoxins, are produced by several species including Aspergillus versicolor and Aspergillus nidulans. Although somewhat less toxic and carcinogenic than aflatoxins, the sterigmatocystins produced by A nidulans and A. versicolor share common biochemical pathways, homologous genes, and regulatory mechanisms to aflatoxins [12,22]. In A. flavus and A. parasiticus a complete aflatoxin pathway gene cluster consisting 30 genes or open reading frames (ORFs) has been confirmed within an 80 kb DNA sequence [12].

Aspergillus genomics was initiated during the late 20th century by coordinated international efforts to sequence three genomes: the medically important Aspergillus fumigatus [23], the biological model A. nidulans [24], and the industrially important fungus A. oryzae [32]. The papers describing these three genomes were published concurrently in Nature in 2005. In the early 21st century, A. flavus (strain: NRRL 3357) whole genome sequencing was initiated in order to study aflatoxin biosynthesis and genetic regulation for food safety, and the sequencing was completed in 2005 [26]. Primary assembly indicated that the A. flavus genome consists of 8 chromosomes and a genome size of about 36.8 Mb. Preliminary annotation demonstrated that there are 13,485 functional genes in the A. flavus genome, a number similar to those of other Aspergillus species [23,24,27,28]. Using the Secondary Metabolite Unique Region Finder (SMURF) program [29], fifty-six (56) SM gene clusters were identified in A. flavus and their relative physical locations in the genome were determined. The aflatoxin gene cluster is located on chromosome III near a sub-telomeric region [30,31]. The sequence data have been deposited in the NCBI GenBank database (http://www. ncbi.nlm.nih.gov) under WGS accession AAIH02000000 and the Genome Announcement was submitted to ASM [32]. The data are also available through the A. flavus website (http:// www.aspergillusflavus.org), Aspergillus Comparative Database of The Broad Institute at MIT (http://www.broadinstitute. org/annotation/genome/aspergillus_group/MultiHome.html), and Central Aspergillus Data Repository in the United Kingdom (http://www.cadre-genomes.org.uk/aspergillus_links.html).

Comparative genomics studies of the aflatoxin-producing A. flavus strain NRRL 3357 indicated that it is very similar to A. oryzae in genome size (36.7 Mb) and the number of predicted genes (12,079). Both genomes are enriched in genes for SM. The A. flavus and A. oryzae genomes are predicted to have 35 vs. 30 polyketide synthases, 24 vs. 24 non-ribosomal peptide synthases, and 122 vs. 151 P450 enzymes, respectively. There are 255 genes unique to A. flavus and 299 genes unique to A. oryzae.

Genomes of several additional aflatoxin-producing Aspergillus strains also have been sequenced. A. parasiticus is a soil-born pathogen that infects peanut and produces large amounts of aflatoxins (B1 , B2 , G1 , and G2 ). The A. parasiticus strain SU-1 genome has been recently sequenced [33]. The A. parasiticus SU-1 genome is estimated to be about 39 Mb in size and predicted to consist of 8 chromosomes with similar sizes to those of A. flavus 3357. Although, the SU-1 genome size (39Mb) is 2 Mb larger than A. flavus NRRL 3357 (36.8 Mb), the number of functional genes in both genomes is similar (13,290 and 13,485 genes respectively). About 4% of the A. flavus 3357 ORFs have no detectable homolog in the A. parasiticus SU-1 genome [33]. Both genomes share greater than 90% sequence identity over more than 90% of the genome, and both genomes contain about fifty-six SM gene clusters as detected by SMURF [29]. In an independent effort, A. parasiticus SU-1 and another aflatoxin-producing A. flavus strain #70, also have been sequenced. The sequence data are under annotation and analysis (Yu et al, unpublished). A. flavus #70 produces small sclerotia and large amounts of aflatoxins as compared with the previously sequenced A. flavus NRRL 3357 which produces large sclerotia. A. flavus strain #70 is highly virulent and causes infection in cotton bolls. Future studies will attempt to identify those factors that contribute to its virulence and sclerotial morphology.

The sequence of Aspergillus niger, a member of the black aspergilli that is widely used in biotechnology for the production of food ingredients, pharmaceuticals, and industrial enzymes was published in 2007 [27]. The genome size of A. niger CBS 513.88 was about 33.9 Mb. A total of 14,165 open reading frames were identified and functional predictions were made for 6,506 of these genes. The sequence and annotation data of the above described genomes, and other related Aspergillus genomes, have been curated by the Aspergillus Genome Database (AspGD, http://www.aspgd.org/) [34].

Fusarium toxins and genomics

The genus Fusarium is another widespread group of filamentous fungal species. Some species of Fusarium produce toxigenic SM, including fumonisins and trichothecenes. These Fusarium mycotoxins have the potential to contaminate grains and animal feeds worldwide, requiring the surveillance of international agencies [35].The economic impact of these mycotoxins on health costs and their effect on international trade is estimated to be in the hundreds of millions of dollars annually [36].

Fumonisins are a family of mycotoxins including fumonisin B1 , B2 , B3 , B4 , A1 , A2 , C1 , C3 etc. [16]. Fumonisin-producing species are members of the Fusarium (Gibberella) fujikuroi complex (FFC) [37]. These include F. moniliforme, F. proliferatum, F. verticillioides and F. oxysporum [37]. These fungi are found in soils across the world and have the potential to infect crops, particularly maize (corn) posing an enormous threat to the health of humans and our domesticated animals [38]. Fumonisin B1 has a chemical structure similar to that of sphonganine and sphingosine, both of which are important substrates in sphingolipid metabolism. Fumonisin B1 disrupts sphingolipid metabolism by interfering with its biosynthesis via competitive inhibition of ceramide synthase which thereby blocks the conversion of sphingolipids to ceramides. Human exposure occurs most commonly in populations where maize is the dietary staple. In addition to a suspected association with neural tube defects, fumonisin exposure has been correlated with higher levels of cancer, especially esophageal and liver cancer [39,40]. The fumonisin biosynthetic pathway and cognate loci consist of at least 16 genes [37].

Another major group of mycotoxins produced by Fusarium species is the trichothecenes. Deoxynivalenol (DON) and T-2 toxin are the branched products of the trichothecene pathway. They are commonly produced by at least 24 Fusarium species including F. equisiti, F. graminearum. F. moniliforme and F. sporotrichioides [41]. Seven additional fungal genera are also reported to produce trichothecenes [16]. It is reported that trichothecene biosynthesis involves at least 12 genes [42].

Genome sequencing of mycotoxin-producing Fusarium species started with Fusarium verticilioides Expressed Sequence Tags (EST) reported at a fungal genomics workshop in 2002. The genomes of F. verticillioides [43], F. graminearum [44], F. fujikuroi IMI [45], and F. oxysporum [43] have been sequenced and reported. Comparative genomics studies revealed the genes, gene clusters, and cluster evolution responsible for fumonisin and trichothecene biosynthesis [46]. The whole genome sequence data has facilitated the identification of complete gene clusters involved in SM, pigments, and mycotoxins [37,47].

Penicillium toxins and genomics

Approximately one hundred Penicillium species are capable of producing mycotoxins, however the majority of these are not commonly found in food commodities. Nevertheless, three major mycotoxins produced by Penicillium spp. are a food safety concern to human and animals: ochratoxin A (OTA), patulin, and citrinin [48]. P. verrucosum and P. nodicum as well as A. ochraceus produce OTA. Patulin is produced by a number of species belonging to both Aspergillus and Penicillium [49], however the main producers of patulin are P. expansum species that cause postharvest decay of apple and pears [48,50]. In addition, P. expansum produces citrinin, penicillic acid, penitrem A, and rubratoxin B. P. citrinum is the main producer of citrinin. Genetic and genomic studies on the biosynthesis of these toxins have significantly lagged behind that of aflatoxins and trichothecenes. The biosynthetic pathways of OTA and the genes involved were identified to consist of 3 genes in a 10 kb DNA region in P. nordicum [51]. The patulin biosynthetic pathway is chemically well-characterized. A putative patulin gene cluster was first reported by genome sequencing of non-producing strains of A. fumigatus and A. clavatus [52,53].

The genome sequencing of species in the genus Penicillium was initially started for those with pharmaceutical and industrial value which include: the penicillin-producing P. chrysogenum [54]; the main postharvest pathogen of citrus, P.digitatum [55]; the lignocellulose-degrading P. oxalicum (P.decumbens) [56]; two cheese-related Penicillium species, P. roqueforti and P. camemberti [57], and the endophytic fungal species, P. aurantiogriseum [58]. A strain of P. expansum was sequenced recently in order to learn more about the genes involved in patulin biosynthesis [59]. The patulin gene cluster was first identified in Aspergillus clavatus by whole genome sequencing [53] and predicted by SMURF [29] to consist of 15 genes in the following order: patH, patG, patF, patE, patD, patC, patB, patA, patM, patN, patO, patL, patI, patJ, and patK [53]. The functions of two of the patulin pathway genes encoding for cytochrome P450 type enzymes in A. clavatus were characterized [52]. The patulin gene cluster in P. expansum also was reported [60]. These genes share 60-70% sequence identity to those in Aspergillus clavatus [52,53] although their gene order was different. To understand the pathogenicity and mycotoxin biosynthesis of the blue mold fungus that causes postharvest decay of pome fruit [61],the most virulent and economically significant strain in our collection, P. expansum R19 was sequenced and compared with the less virulent strain P. solitum RS1. The calculated genome size of P. expansum (R19) contained 31,415,732 bps [59]. This is consistent with the genome size reported previously for P. chrysogenum [54]. Preliminary annotation demonstrated that the P. expansum R19 genome harbors 10,554 predicted genes with an average gene length of 1,599 bp. There are 120 tRNA genes and 48 5S rRNA genes respectively. It is estimated that there are 59 gene clusters putatively involved in the biosynthesis of SM as predicted by SMURF[29]. This is similar to the result predicted by the AntiSMASH program, the Antibiotics and Secondary Metabolite Analysis Shell [62], which resulted in 57 clusters. Genes that are putatively involved in spore germination, mycelial growth, and mycotoxin biosynthesis, specifically patulin and citrinin, are under investigation [59]. The genome sequence of P. expansum R19 has been deposited at DDBJ/EMBL/GenBank under the accession JHUC00000000. The version described in this paper is version JHUC01000000. Transcriptome studies on P. expansum and comparison with related non-patulin -producing strains also have been reported [63]. The recently published genomes of Penicillium species [64] indicated that P. expansum contain 55 SM gene clusters.

Advantages and limitations of genomic technologies

The expanding list of sequenced genomes provides new insights into fungal biology, mycotoxin biosynthesis, genetic regulation, pathogenicity, phylogenetic relationships and evolution. The availability of whole genome sequence data makes it possible to predict all of the genes in the genome, and in general the SM pathway genes tend to be grouped together as a cluster [65,66]. Based on the characteristic sequence signature of SM backbone genes, several software tools were developed to rapidly predict SM gene clusters in a given genome. Secondary Metabolite Unique Region Finder (SMURF) was the first software developed [29], followed by AntiSmash program [62]. The two programs give different predictions. For example, in the genomes of A. flavus and A. parasiticus, 56 SM gene clusters were predicted using the SMURF program; when using the AntiSMASH program, about 70 SM gene clusters were predicted, of which some are remnant and incomplete. For each fungal species, the number of SM gene clusters predicted based on genome sequence data is far greater than the number of known SM compounds that have been chemically identified --almost 10 times greater. Therefore, it can be deduced that most SM gene clusters are silent under normal laboratory conditions. It is hypothesized that these clustered SM genes are expressed only under very specific conditions (i.e. temperature, pH, nutrition, biological niche or in a competing situation with other microorganisms) [2]. For that reason, a third SM prediction algorithm, MIDAS-M [66] was developed based on gene expression patterns detected by EST, microarray or RNASeq data. The advantage of MIDAS-M is that this program detects only those SM gene clusters that are expressed. Nevertheless, a major challenge remains in distinguishing functional SM gene clusters from pseudo, nonfunctional, incomplete, or remnant SM gene clusters. This challenge remains a major bottle neck in the ‘post-genomic’ era and will require major technological advances in the functional genetic and/ or mutational analysis arenas to conclusively demonstrate their function.

FUTURE PERSPECTIVE

It has been almost two decades since Professor Joan W. Bennett suggested that fungal biologists should create a “wish list” for fungal genome sequences [4]. Since then, technological breakthroughs (i.e. Next Generation Sequencing) greatly have increased the speed and lowered the cost of sequencing a fungal genome. In fact, the cost per reaction of DNA sequencing has fallen with a Moor’s Law [67]. In order to study fungal biology and evolution, to address important problems associated with energy and the environment, and to explore novel SMs for the pharmaceutical drug discovery, The Joint Genome Institute (JGI) has geared up to sequence 1000 fungal genomes. Currently, the genomes of at least 24 Aspergillus, four Fusarium, and thirteen Penicillium species are curated at JGI MycoCosm (http://genome. jgi-psf.org/programs/fungi/index.jsf). The availability of hundreds of fungal genomes in public databases is a reflection of the significant progress of the field. Moreover, these growing fungal genomics resources will help us to decipher the genes and pathways regulating both mycotoxins and virulence and to learn more about the genes that affect evolutionary adaptability. The RNA-Seq technology has been employed to characterize fungal transcriptomes and to reveal quantitative differences in gene expression between the environmental conditions analyzed. It is anticipated that a high resolution view of entire fungal transcriptomes will allow researchers to identify genes differentially expressed under conditions conducive and nonconducive for mycotoxin production. With the rapid progress in fungal genomics, a vast amount of new information on gene function, genetic regulation and signal transduction will be amassed. It is now time to integrate the brute force approach of combining the gene-by-gene strategy that was so fruitful in the late 20th and early 21st centuries with the mature whole genome approach of the 21st century. It has become apparent that we must stop thinking about the parts and start thinking about the whole. New forms of systems analyses will allow us to understand the incredibly complex interactions between fungal SM and an ever-changing environment. The genetic and genomic resources will significantly enhance our understanding of the mechanisms of mycotoxin production, pathogenicity, and crop-fungal interactions. This information is vital in assisting scientists to discover new pharmaceutical drugs and for devising novel strategies to eliminate mycotoxin contamination thereby resulting in a safer, nutritious and sustainable food and feed supply to nourish a growing planet.

ACKNOWLEDGEMENTS

Use of a company or product name by the U.S. Department of Agriculture does not imply approval or recommendation of the product to the exclusion of others that may also be suitable. This research was made possible by USDA-ARS project no. 1275- 42430-014-00D via National Program 303 Plant Disease.

REFERENCES

1. Keller NP, Turner G, Bennett JW. Fungal secondary metabolism - from biochemistry to genomics. Nat Rev Microbiol. 2005; 3: 937-947.

2. Brakhage AA, Schuemann J, Bergmann S, Scherlach K, Schroeckh V, Hertweck C. Activation of fungal silent gene clusters: a new avenue to drug discovery. Prog Drug Res. 2008; 66: 1, 3-12.

3. Hoffmeister D, Keller NP. Natural products of filamentous fungi: enzymes, genes, and their regulation. Nat Prod Rep. 2007; 24: 393- 416.

4. Bennett JW. White Paper: Genomics for filamentous fungi. Fungal Genet Biol. 1997; 21: 3-7.

5. Yu J, Genetics and biochemistry of mycotoxin synthesis. Arora, DK, Ed. In: Fungal Biotechnology in Agricultural, Food, and Environmental Applications. Marcel Dekker: New York, 2004; pp 343-361.

6. Yu J, Proctor RH, Brown DW, Abe K, Gomi K, Machida M, et al., Genomics of economically significant Aspergillus and Fusarium species. In Applied Mycology and Biotechnology, Arora, DKKhachatouians, GG, Eds. Elsevier: New York, 2004; 4:249-283.

7. Williams JH, Phillips TD, Jolly PE, Stiles JK, Jolly CM, Aggarwal D. Human aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences, and interventions. Am J Clin Nutr. 2004; 80: 1106-1122.

8. Lewis L, Onsongo M, Njapau H, Schurz-Rogers H, Luber G, Kieszak S, et al. Aflatoxin contamination of commercial maize products during an outbreak of acute aflatoxicosis in eastern and central Kenya. Environ Health Perspect. 2005; 113: 1763-1767.

9. Krishnamachari KA, Bhat RV, Nagarajan V, Tilak TB. Hepatitis due to aflatoxicosis: an outbreak of hepatitis in parts of western India. Lancet. 1975; 1: 1061-1063.

10. Townsend CA. Progress towards a biosynthetic rationale of the aflatoxin pathway. Pure Appl. Chem. 1997; 58: 227-238.

11. Yabe K, Chihaya N, Hamamatsu S, Sakuno E, Hamasaki T, Nakajima H, et al. Enzymatic conversion of averufin to hydroxyversicolorone and elucidation of a novel metabolic grid involved in aflatoxin biosynthesis. Appl Environ Microbiol. 2003; 69: 66-73.

12. Yu J, Chang PK, Ehrlich KC, Cary JW, Bhatnagar D, Cleveland TE, et al. Clustered pathway genes in aflatoxin biosynthesis. Appl Environ Microbiol. 2004; 70: 1253-1262.

13. Bennett JW, Arnold J, Genomics for fungi. Howard, RJGow, NAR, Eds. In: The Mycota VIII, Biology of the Fungal Cell. Springer-Verlag, Heidelberg: Berlin, 2001; 267-297.

14. Payne GA, Nierman WC, Wortman JR, Pritchard BL, Brown D, Dean RA, et al. Whole genome comparison of Aspergillus flavus and A. oryzae. Med. Mycol. 2006; 44 Suppl: 9-11.

15. Yu J, Whitelaw CA, Nierman WC, Bhatnagar D, Cleveland TE. Aspergillus flavus expressed sequence tags for identification of genes with putative roles in aflatoxin contamination of crops. FEMS Microbiol Lett. 2004; 237: 333-340.

16. Sweeney MJ, Dobson AD. Mycotoxin production by Aspergillus Fusarium and Penicillium species. Int J Food Microbiol. 1998; 43: 141- 158.

17. Hsieh DPH, Potential human health hazards of mycotoxins. Natori S, Hashimoto, HUeno Y, Eds. In: Mycotoxins and Phycotoxins. Elsevier: Amsterdam, 1989; 69-80.

18. Van Egmond HP. Current situation on regulations for mycotoxins. Overview of tolerances and status of standard methods of sampling and analysis. Food Addit Contam. 1989; 6: 139-188.

19. Allcroft R, Carnaghan RBA, Sargeant K, O’Kelly J. A toxic factor in Brazilian groundnut meal. Vet. Rec. 1961; 73: 428-429.

20. Lancaster MD, Jenkins FP, Philip JM. Toxicity associated with certain samples of ground nuts. Nature. 1961; 192: 1095-1096.

21. Goto T, Wicklow DT, Ito Y. Aflatoxin and cyclopiazonic acid production by a sclerotium-producing Aspergillus tamarii strain. Appl Environ Microbiol. 1996; 62: 4036-4038.

22. Brown DW, Yu JH, Kelkar HS, Fernandes M, Nesbitt TC, Keller NP, et al. Twenty-five coregulated transcripts define a sterigmatocystin gene cluster in Aspergillus nidulans. Proc Natl Acad Sci U S A. 1996; 93: 1418-1422.

23. Nierman WC, Pain A, Anderson MJ, Wortman JR, Kim HS, Arroyo J, et al. Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus. Nature. 2005; 438: 1151-1156.

24. Galagan JE, Calvo SE, Cuomo C, Ma LJ, Wortman JR, Batzoglou S, et al. Sequencing of Aspergillus nidulans and comparative analysis with A. fumigatus and A. oryzae. Nature. 2005; 438: 1105-1115.

25. Machida M, Asai K, Sano M, Tanaka T, Kumagai T, Terai G, et al. Genome sequencing and analysis of Aspergillus oryzae. Nature. 2005; 438: 1157-1161.

26. Payne GA, Yu J, Nierman WC, Machida M, Bhatnagar D, Cleveland TE, et al. A first glance into the genome sequence of Aspergillus flavus. Osmani, SGoldman, G, Eds. In: The ASPERGILLI: Genomics, Medical Aspects, Biotechnol & Res Methods. CRC Press: Boca Raton, FL, 2008; Vol. 26, pp 15-23.

27. Pel HJ, de Winde JH, Archer DB, Dyer PS, Hofmann G, Schaap PJ, et al. Genome sequencing and analysis of the versatile cell factory Aspergillus niger CBS 513.88. Nat Biotechnol. 2007; 25: 221-231.

28. Yu J, Cleveland TE. Aspergillus flavus genomics for discovering genes involved in aflatoxin biosynthesis. . Rimando, AMBaerson, SR, Eds. In: Polyketides Biosynthesis, Biological Activity, and Genetic Engineering. American Chemical Society: Washington, DC. 2007; 955: 246-260.

29. Khaldi N, Seifuddin FT, Turner G, Haft D, Nierman WC, Wolfe KH, et al. SMURF: Genomic mapping of fungal secondary metabolite clusters. Fungal Genet Biol. 2010; 47: 736-741.

30. Yu J, Nierman WC, Bennett JW, Cleveland TE, Bhatnagar D, Campbell CC, et al. Genetics and genomics of Aspergillus flavus. Rai, MKKovics, G, Eds. In: Progress in Mycology. Scientific Publishers. 2010; 51-73.

31. Yu J, Payne GA, Nierman WC, Machida M, Bennett JW, Campbell BC, et al. Aspergillus flavus genomics as a tool for studying the mechanism of aflatoxin formation. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2008; 25: 1152-1157.

32. Nierman WC, Yu J, Fedorova-Abrams ND, Losada L, Cleveland TE, Bhatnagar D, et al. Genome Sequence of Aspergillus flavus NRRL 3357, a Strain That Causes Aflatoxin Contamination of Food and Feed. Genome Announc. 2015; 3.

33. Linz JE, Wee J, Roze LV. Aspergillus parasiticus SU-1 genome sequence, predicted chromosome structure, and comparative gene expression under aflatoxin-inducing conditions: evidence that differential expression contributes to species phenotype. Eukaryot Cell. 2014; 13: 1113-1123.

34. Arnaud MB, Cerqueira GC, Inglis DO, Skrzypek MS, Binkley J, Chibucos MC, et al. The Aspergillus Genome Database (AspGD): recent developments in comprehensive multispecies curation, comparative genomics and community resources. Nucleic Acids Res. 2012; 40: 653- 659.

35. Placinta CM, E’Mello JPF, Macdonald AMC. A review of worldwide contamination of cereal grains and animal feed with Fusarium mycotoxins. Animal Feed Science and Technology. 1999; 78: 21-37.

36. Wu F. Measuring the economic impacts of Fusarium toxins in animal feeds. Animal Feed Sci Tech. 2007; 137: 363-374.

37. Proctor RH, Van Hove F, Susca A, Stea G, Busman M, van der Lee T, Waalwijk C. Birth, death and horizontal transfer of the fumonisin biosynthetic gene cluster during the evolutionary diversification of Fusarium. Mol Microbiol. 2013; 90: 290-306.

38. Marasas WFO, Nelson PE. Introduction to the Mycology, Plant Pathology, Chemistry, Toxicology, and Pathology of Naturally Occurring Mycotoxicoses In Animals and Man. In Mycotoxicology, The Pennsylvania State University Press: University Park, PA, 1987.

39. Marasas WF, Riley R, Hendricks KA, Stevens VL, Sadler TW, Gelineauvan Waes J, et al. Fumonisins disrupt sphingolipid metabolism, folate transport, and neural tube development in embryo culture and in vivo: a potential risk factor for human neural tube defects among populations consuming fumonisin-contaminated maize. J Nutri. 2004; 134: 711-716.

40. Shephard GS, Thiel PG, Stockenström S, Sydenham EW. Worldwide survey of fumonisin contamination of corn and corn-based products. J AOAC Int. 1996; 79: 671-687.

41. Marasas WFO, Nelson PE, Tousson TA. Toxigenic Fusarium species: Identity and mycotoxicology. University Part, PA: Pennsylvania State University Press. 1984.

42. Desjardins AE, Fusarium mycotoxins: chemistry, genetics, and biology. In The American Phytopathological Society, St. Paul, Minnesota, USA, 2006; p 260 pp.

43. Ma LJ, van der Does HC, Borkovich KA, Coleman JJ, Daboussi MJ, Di Pietro A, et al. Comparative genomics reveals mobile pathogenicity chromosomes in Fusarium. Nature. 2010; 464: 367-373.

44. Cuomo CA, Güldener U, Xu JR, Trail F, Turgeon BG, Di Pietro A, et al. The Fusarium graminearum genome reveals a link between localized polymorphism and pathogen specialization. Science. 2007; 317: 1400- 1402.

45. Wiemann P, Sieber CM, von Bargen KW, Studt L, Niehaus EM, Espino JJ, et al. Deciphering the cryptic genome: genome-wide analyses of the rice pathogen Fusarium fujikuroi reveal complex regulation of secondary metabolism and novel metabolites. PLoS Pathog. 2013; 9: ePub: e1003475.

46. Ma LJ, Geiser DM, Proctor RH, Rooney AP, O’Donnell K, Trail F, et al. Fusarium pathogenomics. Annu Rev Microbiol. 2013; 67: 399-416.

47. Brown DW, Butchko RA, Busman M, Proctor RH. Identification of gene clusters associated with fusaric acid, fusarin, and perithecial pigment production in Fusarium verticillioides. Fungal Genet Biol. 2012; 49: 521-532.

48. Frisvad JC, Samson RA, Polyphasic taxonomy of Penicillium subgenus Penicillium: A guide to identification of food and air-borne terverticillate Penicillia and their mycotoxins. Samson, RAFrisvad, JC, Eds. In: Studies in Mycology, subgenus Penicillium: new taxonomic schemes, mycotoxins and other extrolites,. 2004; 49: 1-174.

49. Pitt JI. Toxigenic Penicillium species. Doyle, MP,Beuchat, LRMontrville, TJ, Eds. In Food Microbiology, Fundamentals and Frontiers.. ASM Press: Washington, DC. 1997; 406-418.

50. Jurick WM, Janisiewicz WJ, Saftner RA, Vico I, Gaskins VL, Park E, et al. Identification of wild applegermplasm (Malus spp.) accessions with resistance to the postharvest decay pathogens Penicillium expansum and Colletotrichum acutatum. Plant Breeding. 2011; 130: 481-486.

51. Geisen R, Schmidt-Heydt M, Karolewiez A. A gene cluster of the ochratoxin A biosynthetic genes inPenicillium. Mycotoxin Res. 2006; 22: 134-141.

52. Artigot MP, Loiseau N, Laffitte J, Mas-Reguieg L, Tadrist S, Oswald IP, et al. Molecular cloning and functional characterization of two CYP619 cytochrome P450s involved in biosynthesis of patulin in Aspergillus clavatus. Microbiology. 2009; 155: 1738-1747.

53. Fedorova ND, Khaldi N, Joardar VS, Maiti R, Amedeo P, Anderson MJ, et al. Genomic islands in the pathogenic filamentous fungus Aspergillus fumigatus. PLoS Genet. 2008; 4: e1000046.

54. van den Berg MA, Albang R, Albermann K, Badger JH, Daran JM, Driessen AJ, et al. Genome sequencing and analysis of the filamentous fungus Penicillium chrysogenum. Nat Biotechnol. 2008; 26: 1161- 1168.

55. Marcet-Houben M, Ballester AR, de la Fuente B, Harries E, Marcos JF, Gonzalez-Candelas L, et al. Genome sequence of the necrotrophic fungus Penicillium digitatum, the main postharvest pathogen of citrus. BMC Genomics. 2012; 13: 646.

56. Liu G, Zhang L, Wei X, Zou G, Qin Y, Ma L, et al. Genomic and secretomic analyses reveal unique features of the lignocellulolytic enzyme system of Penicillium decumbens. PLoS One. 2013; 8: e55185.

57. Cheeseman K, Ropars J, Renault P, Dupont J, Gouzy J, Branca A, et al. Multiple recent horizontal transfers of a large genomic region in cheese making fungi. Nat Commun. 2014; 5: 2876.

58. Yang Y, Zhao H, Barrero RA, Zhang B, Sun G, Wilson IW, et al. Genome sequencing and analysis of the paclitaxel-producing endophytic fungus Penicillium aurantiogriseum NRRL 62431. BMC Genomics. 2014; 15: 69.

59. Yu J, Jurick WM 2nd, Cao H, Yin Y, Gaskins VL, Losada L, et al. Draft Genome Sequence of Penicillium expansum Strain R19, Which Causes Postharvest Decay of Apple Fruit. Genome Announc. 2014; 2.

60. Tannous J, El Khoury R, Snini SP, Lippi Y, El Khoury A, Atoui A, et al. Sequencing, physical organization and kinetic expression of the patulin biosynthetic gene cluster from Penicillium expansum. Int J Food Microbiol. 2014; 189: 51-60.

61. Spotts RA, Cervantes LA, Mielke EA. Variability in postharvest decay among apple cultivars. Plant Dis. 1999; 83: 1051.

62. Medema MH, Blin K, Cimermancic P, de Jager V, Zakrzewski P, Fischbach MA, et al. antiSMASH: rapid identification, annotation and analysis of secondary metabolite biosynthesis gene clusters in bacterial and fungal genome sequences. Nucleic Acids Res. 2011; 39: W339-346.

63. Ballester AR, Marcet-Houben M, Levin E, Sela N, Selma-Lázaro C, Carmona L, et al. Genome, transcriptome, and functional analyses of Penicillium expansum provide new insights into secondary metabolism and pathogenicity. Mol Plant-Microbe Interact. 2015; 28: 232-248.

64. Li B, Zong Y, Du Z, Chen Y, Zhang Z, Qin G, et al. Genomic characterization reveals insights into patulin biosynthesis and pathogenicity in Penicillium species. Mol Plant Microbe Interact. 2015.

65. Keller NP, Hohn TM. Metabolic pathway gene clusters in filamentous fungi. Fungal Genet. Biol. 1997; 21: 17-29.

66. Umemura M, Koike H, Nagano N, Ishii T, Kawano J, Yamane N, et al. MIDDAS-M: motif-independent de novo detection of secondary metabolite gene clusters through the integration of genome sequencing and transcriptome data. PLoS One. 2013; 8: e84028.

67. Moore G. Cramming more components onto integrated circuits. Electronics 1965: 38.

Received : 10 May 2015
Accepted : 16 Apr 2015
Published : 20 Apr 2015
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X